부산대학교 도서관

박찬호 (Chanho Park); 곽재우 (Jaewoo Kwak); 임수연 (Su Yeon Lim); 김현욱 (Hyun-Ouk Kim); 임광석 (Kwang Suk Lim)

KSBB Journal. 2025-03 40(1):22-31

Pandey, Janardan P.; Namboodiri, Aryan M.; Nietert, Paul J.

Immunogenetics. 77(1)

Hsieh, Ming-Ching; Dorofejeva, Kristiina; Zhang, Jingming; Vy, Diane L.; Qian, Jun; Matathia, Alice M.; Blanc, Timothy; Li, Chao Richard; Parekh, Babita S.

Antibodies (2073-4468). Dec2025, Vol. 14 Issue 4, p89. 26p.

Pamonsupornwichit, Thanathat; Thongheang, Kanyarat; Takheaw, Nuchjira; Sornsuwan, Kanokporn; Htet, Zaw Ye; Juntit, On-anong; Jantaree, Phatcharida; Tayapiwatana, Chatchai

Cancer Immunology, Immunotherapy. 74(11)

Sana Guizani; Aymen Ajina

Studies in Economics and Finance. 42:1134-1147

Veitonmäki N; Pure Biologics S. A., Wroclaw, Poland.; Kostyn A; Pure Biologics S. A., Wroclaw, Poland.; Kołt S; Pure Biologics S. A., Wroclaw, Poland.; Ziemblicka A; Pure Biologics S. A., Wroclaw, Poland.; Romanowska B; Pure Biologics S. A., Wroclaw, Poland.; Oleksy S; Pure Biologics S. A., Wroclaw, Poland.; Krzywińska E; Pure Biologics S. A., Wroclaw, Poland.; Sołtys K; Pure Biologics S. A., Wroclaw, Poland.; Świderski Ł; Pure Biologics S. A., Wroclaw, Poland.; Naporowski P; Pure Biologics S. A., Wroclaw, Poland.; Mamczur P; Pure Biologics S. A., Wroclaw, Poland.; Świtoń M; Pure Biologics S. A., Wroclaw, Poland.; Orłowski M; Pure Biologics S. A., Wroclaw, Poland.; Department of Biochemistry, Molecular Biology and Biotechnology, Faculty of Chemistry, Wroclaw University of Science and Technology, Wroclaw, Poland.; Zhang Y; GemPharmatech Co. Ltd., Nanjing, China.; Xu J; GemPharmatech Co. Ltd., Nanjing, China.; Andrzejczak A; Laboratory of Genetics and Epigenetics of Human Diseases, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland.; Bielawska-Pohl A; Laboratory of Biology of Stem and Neoplastic Cells, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland.; Karabon L; Laboratory of Genetics and Epigenetics of Human Diseases, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland.; Wołowiec D; Clinical Department of Hematology, Cell Therapies and Internal Diseases, Wroclaw Medical University, Wrocław, Poland.; Sime W; IVRS AB, Lund, Sweden.; Massoumi R; IVRS AB, Lund, Sweden.; Deshmukh S; Pure Biologics S. A., Wroclaw, Poland.; Kołodziejski J; Pure Biologics S. A., Wroclaw, Poland.; Klaus T; Pure Biologics S. A., Wroclaw, Poland.; Spee P; Pure Biologics S. A., Wroclaw, Poland.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Li, Ke; Zhao, Zhiyuan; Huang, Haojun; Luo, Shouxi; Xing, Huanlai; Yang, Qiang

2024 IEEE International Conference on High Performance Computing and Communications (HPCC) HPCC High Performance Computing and Communications (HPCC), 2024 IEEE International Conference on. :1465-1475 Dec, 2024

Patrick Ross; Tania Cid; Monica Fernández Quintero; Johannes Loeffler; Hijab Fatima; Dan P Leaman; Jessica Matthias; Kathryn Spencer; Michael B Zwick; Scott C Henderson; Andrew B Ward; Emily M Mace; Charles Daniel Murin

J Immunol

Richard J; Centre de Recherche du CHUM, Montréal, Québec, Canada.; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montréal, Québec, Canada.; Grunst MW; Department of Microbial Pathogenesis, Yale University School of Medicine, New Haven, CT, USA.; Niu L; Infectious Diseases Division, Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.; Díaz-Salinas MA; Department of Microbiology, University of Massachusetts Chan Medical School, Worcester, MA, USA.; Zhu L; Department of Internal Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA.; Tolbert WD; Infectious Diseases Division, Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.; Marchitto L; Centre de Recherche du CHUM, Montréal, Québec, Canada.; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montréal, Québec, Canada.; Zhou F; Unit on Structural Biology, Division of Basic and Translational Biophysics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, MD, USA.; Bourassa C; Centre de Recherche du CHUM, Montréal, Québec, Canada.; Kim H; Department of Internal Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA.; Boodapati SLT; Department of Internal Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA.; Yang D; Department of Chemistry, School of Arts and Sciences, University of Pennsylvania, Philadelphia, PA, USA.; Chiu TJ; Department of Chemistry, School of Arts and Sciences, University of Pennsylvania, Philadelphia, PA, USA.; Chen HC; Department of Chemistry, School of Arts and Sciences, University of Pennsylvania, Philadelphia, PA, USA.; Benlarbi M; Centre de Recherche du CHUM, Montréal, Québec, Canada.; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montréal, Québec, Canada.; Beaudoin-Bussières G; Centre de Recherche du CHUM, Montréal, Québec, Canada.; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montréal, Québec, Canada.; Gottumukkala S; Infectious Diseases Division, Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.; Li W; Department of Microbial Pathogenesis, Yale University School of Medicine, New Haven, CT, USA.; Dionne K; Centre de Recherche du CHUM, Montréal, Québec, Canada.; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montréal, Québec, Canada.; Bélanger É; Centre de Recherche du CHUM, Montréal, Québec, Canada.; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montréal, Québec, Canada.; Chatterjee D; Centre de Recherche du CHUM, Montréal, Québec, Canada.; Medjahed H; Centre de Recherche du CHUM, Montréal, Québec, Canada.; Hendrickson WA; Department of Biochemistry and Molecular Biophysics, Columbia University, New York, NY, USA.; Department of Physiology and Cellular Biophysics, Columbia University, New York, NY, USA.; Sodroski J; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Microbiology, Harvard Medical School, Boston, MA, USA.; Lang ZC; Laboratory of Cell Biology, National Cancer Institute, NIH, Bethesda, USA.; Morton AJ; Laboratory of Cell Biology, National Cancer Institute, NIH, Bethesda, USA.; Huang RK; Laboratory of Cell Biology, National Cancer Institute, NIH, Bethesda, USA.; Matthies D; Unit on Structural Biology, Division of Basic and Translational Biophysics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, MD, USA.; Smith AB 3rd; Department of Chemistry, School of Arts and Sciences, University of Pennsylvania, Philadelphia, PA, USA.; Kumar P; Department of Internal Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA. priti.kumar@yale.edu.; Mothes W; Department of Microbial Pathogenesis, Yale University School of Medicine, New Haven, CT, USA. walther.mothes@yale.edu.; Munro JB; Department of Microbiology, University of Massachusetts Chan Medical School, Worcester, MA, USA. james.munro@umassmed.edu.; Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, MA, USA. james.munro@umassmed.edu.; Pazgier M; Infectious Diseases Division, Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, USA. marzena.pazgier@usuhs.edu.; Finzi A; Centre de Recherche du CHUM, Montréal, Québec, Canada. andres.finzi@umontreal.ca.; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montréal, Québec, Canada. andres.finzi@umontreal.ca.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of VAY736 in Autoimmune Hepatitis
Cholankeril G, Vierling JM. The clinical imperative of a complete biochemical response to immunosuppression in autoimmune hepatitis: Close is not good enough! Hepatology. 2024 Mar 1;79(3):529-531. doi: 10.1097/HEP.0000000000000597. Epub 2023 Sep 18. No abstract available.
Chung YY, Rahim MN, Heneghan MA. Autoimmune hepatitis and pregnancy: considerations for the clinician. Expert Rev Clin Immunol. 2022 Apr;18(4):325-333. doi: 10.1080/1744666X.2022.2044307. Epub 2022 Mar 2.

Wang, Yingdan; Ji, Ping; Liu, Qianying; Jia, Nannan; Ma, Yunping; Yuan, Tianyi; Rehati, Palizhati; Chen, Jiali; Wen, Yumei; Wu, Fan; Huang, Jinghe

Cell Discovery. 11(1)

Sievers, Benjamin L.; Altaf, Mazharul; Cheng, Mark T. K.; Kamelian, Kimia; Cormie, Claire; Doffinger, Rainer; Gupta, Ravindra K.

npj Vaccines. 10(1)

Du, Ruoxin; Cao, Changqing; Fan, Dong; Li, Guodong; Pu, Shuangpeng; Xu, Xinyao; Liu, Mengmeng; Shi, Gege; Wu, Yuxin; Hao, Qiang; Gao, Yuan; Zhang, Juliang; Zhao, Huadong; Zhang, Cun

Cell Communication and Signaling. 23(1)

Liu, Xiang ; Zhang, Meng ; Luo, Yi ; Yan, Shijie ; Xu, Haoran ; Yao, Yao ; Xu, Farong ; Liu, Pinghuang

In Veterinary Microbiology June 2025 305

A Multicenter, Randomized, Open-label, Phase II Trial Aiming to Evaluate the Impact of Pegfilgrastim on Trastuzumab Anti-tumor Effect and ADCC in Operable HER2 Positive Breast Cancer Patients
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010 Dec 15;127(12):2893-917. doi: 10.1002/ijc.25516.
Wolff AC, Hammond ME, Hicks DG, Dowsett M, McShane LM, Allison KH, Allred DC, Bartlett JM, Bilous M, Fitzgibbons P, Hanna W, Jenkins RB, Mangu PB, Paik S, Perez EA, Press MF, Spears PA, Vance GH, Viale G, Hayes DF; American Society of Clinical Oncology; College of American Pathologists. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. J Clin Oncol. 2013 Nov 1;31(31):3997-4013. doi: 10.1200/JCO.2013.50.9984. Epub 2013 Oct 7.
Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A, McShane LM, Paik S, Pegram MD, Perez EA, Press MF, Rhodes A, Sturgeon C, Taube SE, Tubbs R, Vance GH, van de Vijver M, Wheeler TM, Hayes DF; American Society of Clinical Oncology/College of American Pathologists. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch Pathol Lab Med. 2007;131(1):18-43. doi: 10.5858/2007-131-18-ASOCCO.
Zhou BP, Hung MC. Dysregulation of cellular signaling by HER2/neu in breast cancer. Semin Oncol. 2003 Oct;30(5 Suppl 16):38-48. doi: 10.1053/j.seminoncol.2003.08.006.
Slamon D, Eiermann W, Robert N, Pienkowski T, Martin M, Press M, Mackey J, Glaspy J, Chan A, Pawlicki M, Pinter T, Valero V, Liu MC, Sauter G, von Minckwitz G, Visco F, Bee V, Buyse M, Bendahmane B, Tabah-Fisch I, Lindsay MA, Riva A, Crown J; Breast Cancer International Research Group. Adjuvant trastuzumab in HER2-positive breast cancer. N Engl J Med. 2011 Oct 6;365(14):1273-83. doi: 10.1056/NEJMoa0910383.
Untch M, Rezai M, Loibl S, Fasching PA, Huober J, Tesch H, Bauerfeind I, Hilfrich J, Eidtmann H, Gerber B, Hanusch C, Kuhn T, du Bois A, Blohmer JU, Thomssen C, Dan Costa S, Jackisch C, Kaufmann M, Mehta K, von Minckwitz G. Neoadjuvant treatment with trastuzumab in HER2-positive breast cancer: results from the GeparQuattro study. J Clin Oncol. 2010 Apr 20;28(12):2024-31. doi: 10.1200/JCO.2009.23.8451. Epub 2010 Mar 22.
Gianni L, Eiermann W, Semiglazov V, Manikhas A, Lluch A, Tjulandin S, Zambetti M, Vazquez F, Byakhow M, Lichinitser M, Climent MA, Ciruelos E, Ojeda B, Mansutti M, Bozhok A, Baronio R, Feyereislova A, Barton C, Valagussa P, Baselga J. Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort. Lancet. 2010 Jan 30;375(9712):377-84. doi: 10.1016/S0140-6736(09)61964-4.
Gianni L, Eiermann W, Semiglazov V, Lluch A, Tjulandin S, Zambetti M, Moliterni A, Vazquez F, Byakhov MJ, Lichinitser M, Climent MA, Ciruelos E, Ojeda B, Mansutti M, Bozhok A, Magazzu D, Heinzmann D, Steinseifer J, Valagussa P, Baselga J. Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort. Lancet Oncol. 2014 May;15(6):640-7. doi: 10.1016/S1470-2045(14)70080-4. Epub 2014 Mar 20.
Kute T, Stehle JR Jr, Ornelles D, Walker N, Delbono O, Vaughn JP. Understanding key assay parameters that affect measurements of trastuzumab-mediated ADCC against Her2 positive breast cancer cells. Oncoimmunology. 2012 Sep 1;1(6):810-821. doi: 10.4161/onci.20447.
Deauvieau F, Ollion V, Doffin AC, Achard C, Fonteneau JF, Verronese E, Durand I, Ghittoni R, Marvel J, Dezutter-Dambuyant C, Walzer T, Vie H, Perrot I, Goutagny N, Caux C, Valladeau-Guilemond J. Human natural killer cells promote cross-presentation of tumor cell-derived antigens by dendritic cells. Int J Cancer. 2015 Mar 1;136(5):1085-94. doi: 10.1002/ijc.29087. Epub 2014 Aug 6.
Hernandez-Ilizaliturri FJ, Jupudy V, Ostberg J, Oflazoglu E, Huberman A, Repasky E, Czuczman MS. Neutrophils contribute to the biological antitumor activity of rituximab in a non-Hodgkin's lymphoma severe combined immunodeficiency mouse model. Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5866-73.
Cornet S, Mathe D, Chettab K, Evesque A, Matera EL, Tredan O, Dumontet C. Pegfilgrastim Enhances the Antitumor Effect of Therapeutic Monoclonal Antibodies. Mol Cancer Ther. 2016 Jun;15(6):1238-47. doi: 10.1158/1535-7163.MCT-15-0759. Epub 2016 Mar 17.
Cartron G, Zhao-Yang L, Baudard M, Kanouni T, Rouille V, Quittet P, Klein B, Rossi JF. Granulocyte-macrophage colony-stimulating factor potentiates rituximab in patients with relapsed follicular lymphoma: results of a phase II study. J Clin Oncol. 2008 Jun 1;26(16):2725-31. doi: 10.1200/JCO.2007.13.7729. Epub 2008 Apr 21.
Bossuyt V, Provenzano E, Symmans WF, Boughey JC, Coles C, Curigliano G, Dixon JM, Esserman LJ, Fastner G, Kuehn T, Peintinger F, von Minckwitz G, White J, Yang W, Badve S, Denkert C, MacGrogan G, Penault-Llorca F, Viale G, Cameron D; Breast International Group-North American Breast Cancer Group (BIG-NABCG) collaboration. Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration. Ann Oncol. 2015 Jul;26(7):1280-91. doi: 10.1093/annonc/mdv161. Epub 2015 May 27.
Lin Y, Kikuchi S, Obata Y, Yagyu K; Tokyo Research Group on Prevention of Gastric Cancer. Serum levels of transforming growth factor beta1 are significantly correlated with venous invasion in patients with gastric cancer. J Gastroenterol Hepatol. 2006 Feb;21(2):432-7. doi: 10.1111/j.1440-1746.2005.03939.x.
Tas F, Yasasever CT, Karabulut S, Tastekin D, Duranyildiz D. Serum transforming growth factor-beta1 levels may have predictive and prognostic roles in patients with gastric cancer. Tumour Biol. 2015 Mar;36(3):2097-103. doi: 10.1007/s13277-014-2817-9. Epub 2014 Nov 13.
Lin Y, Kikuchi S, Tamakoshi A, Obata Y, Yagyu K, Inaba Y, Kurosawa M, Kawamura T, Motohashi Y, Ishibashi T; JACC Study Group. Serum transforming growth factor-beta1 levels and pancreatic cancer risk: a nested case-control study (Japan). Cancer Causes Control. 2006 Oct;17(8):1077-82. doi: 10.1007/s10552-006-0048-0.
Zhao J, Liang Y, Yin Q, Liu S, Wang Q, Tang Y, Cao C. Clinical and prognostic significance of serum transforming growth factor-beta1 levels in patients with pancreatic ductal adenocarcinoma. Braz J Med Biol Res. 2016 Jul 25;49(8):e5485. doi: 10.1590/1414-431X20165485.
Tas F, Karabulut S, Yasasever CT, Duranyildiz D. Serum transforming growth factor-beta 1 (TGF-beta1) levels have diagnostic, predictive, and possible prognostic roles in patients with melanoma. Tumour Biol. 2014 Jul;35(7):7233-7. doi: 10.1007/s13277-014-1984-z. Epub 2014 Apr 27.
Xu S, Yang S, Sun G, Huang W, Zhang Y. Transforming growth factor-beta polymorphisms and serum level in the development of osteosarcoma. DNA Cell Biol. 2014 Nov;33(11):802-6. doi: 10.1089/dna.2014.2527. Epub 2014 Aug 6.

Choi, Seung Beom; Lee, Hyun Tae; Gu, Nahyeon; Jang, Yu-Jeong; Park, Ui Beom; Jeong, Tae Jun; Lee, Sang Hyung; Heo, Yong-Seok

International Journal of Molecular Sciences. Jun2025, Vol. 26 Issue 12, p5500. 13p.

Oluka, Gerald Kevin ; Katende, Joseph Ssebwana ; Kato, Laban ; Ankunda, Violet ; Sembera, Jackson ; Ejou, Peter ; Odoch, Geoffrey ; Namuyanja, Angella ; Kaleebu, Pontiano ; Serwanga, Jennifer

In iScience 20 February 2026 29(2)

Cao, Fei; Xu, Yuandong; Guan, Yupeng; Zhang, Kexin; Qiu, Haowei; Xu, Zhen; He, Yunru; Xiao, Ze Xiu; Zha, Gao-feng; Pang, Jun

Journal of Nanobiotechnology. 23(1)

Roos Vincken; Uxue Armendáriz-Martínez; Ana Ruiz-Sáenz

Front Immunol
Frontiers in Immunology, Vol 16 (2025)

Wake Forest Alzheimer's Disease Clinical Core